Prima Biomed Ltd

PRR0.03-0.002 (6.67%)17/10 at close
View full PRR analysis
Volume
13,663,904
Shares Issued
2,362,662,532
Dividend Yield
Market Cap
70,879,875.96
Price Book Value
PER
-6.67
PRR.ASX full report delivery
PRR
Send Report
The free stock analysis report of PRR will arrive soon. Your email provider may divert this report to a folder other than your inbox. If you don’t receive the report, please call 1-888-658-7638. Thank You.
Page 1 of 10
  1. overdue for yearly sp movement

    ken_45 Teased early Jan
    5
    Replies
    130
    Views
  2. Preliminary Final Report 30 June 2015

    malaroo Looks to have broken down , where is the next buying opportunity, 4.8c
    23
    Replies
    1.2k
    Views
  3. cancer break?

    peter121 About Mayo Clinic Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, who
    0
    Replies
    218
    Views
  4. From US overnight

    peter121 PBMD Prima Biomed Ltd 1.06 -0.07 -6.19% 1.13 0.96 858,331
    0
    Replies
    312
    Views
  5. Price outlook

    peter121 Hello Peter, This email is to say Thank You for being part of our EGM in person. I appreciator your ongoing support as we seek t
    74
    Replies
    5.2k
    Views
  6. Removal of cancer protein could be the cure

    1sharetrader1 Have a look at The Tech Journal,and this storey A new protein killer could be the much sought after cure for cancer This storey
    0
    Replies
    203
    Views
  7. CVAC SHOWS OVERALL SURVIVAL BENEFIT IN SECOND

    PrimalFear Hi Pee Jay, Thank you for reply,PRR has a good outlook , Hope it will be the case for patients and Investors.
    22
    Replies
    2.0k
    Views
  8. Cleansing Notice

    madmax123 On 15th May 2015, Prima Bio Med Ltd issued 22,936,950 fully paid ordinary shares in accordance with the terms of its Share Purch
    0
    Replies
    277
    Views
  9. Prima on a slippery slide

    Pee Jay Don't buy in to the negativity surrounding Prima, nothing has changed- we are still expecting very good OS data on Cvac either J
    1
    Reply
    402
    Views
  10. On the move

    Pee Jay Indeed, something nice is looming! Van Leeuwenhoek have a target of 11c in their latest research report. But have a feeling sp w
    6
    Replies
    1.3k
    Views
  11. CVAC DEMONSTRATES OVERALL SURVIVAL BENEFIT IN

    Tulipmania CVAC DEMONSTRATES OVERALL SURVIVAL BENEFIT IN SECOND REMISSION OVARIAN CANCER :shock :cool: :cool: Well done this is fantastic n
    0
    Replies
    437
    Views
  12. analysis from todays chart

    mr X wondering if anyone has an opinion on which direction the price will head tomorrow? After making " the most siginificant announ
    0
    Replies
    446
    Views
  13. Buying opportunity

    Pee Jay Another medical life changer with CVac, this company unloved by the market even with most recent announcements. No reason why th
    8
    Replies
    1.3k
    Views
  14. PRIMA RECEIVES US PATENT GRANT FOR CVAC

    mabrook I was beggining to think I was the only one following this stock. It is starting to look cheap, either as a growth stock or a ta
    1
    Reply
    595
    Views
  15. New European based CEO

    mabrook European based CEO, where the trials and manufacture take place. A sensible move to streamline the organisation in my opinion.
    0
    Replies
    472
    Views
  16. Stalemate

    mabrook Lots of buyers and sellers sitting either side of this price .045/.046 Price needs to move to trigger next round of trades. I am
    0
    Replies
    559
    Views
  17. CVac demonstrates positive trend in OS

    Pee Jay More great news from PRR, there's no reason why with this third great announcement in the past 3 weeks the SP shouldn't be well
    0
    Replies
    580
    Views
  18. prr price

    whitto84 hello can anyone give me an idea of future prr pricing ,have bought some shares and wondering how long before I can expect decen
    0
    Replies
    667
    Views
  19. CVac US Patent Allowed

    peter121 It has been long term already!!! 40c in one stage-have U bought????
    4
    Replies
    779
    Views
  20. Rocky Balboa stcok

    Goldgun Good call MR BEAN nailed it matey Stanster not such a great call its ok PDN will rebound I'm sure:)
    6
    Replies
    801
    Views
  21. CVAc demonstrates improvement in PFS

    Goldgun But who was MR Bean heavily criticised even banned by the looks ......was it a fluke this guys picks went up? what 40% Great new
    1
    Reply
    557
    Views
  22. PRIMA BIOMEDS CVAC GRANTED FAST TRACK D

    Punter_44 Not selling, Last time jumped on 3.9c sold 6c
    4
    Replies
    569
    Views
  23. Prima getting primed or about to tank??

    MLF Hi Grumpbum, PRR ann. Removed from ASX300? However Sp looks low! Mlf :D
    1
    Reply
    605
    Views
  24. Can-004 Trial Amendment approved in Belgium

    watson Frost & Sullivan Award Emerging Biotech Company Of the Year 2014 http://www.sacbee.com/2014/02/19/6173117/frost-sullivan-honou
    18
    Replies
    1.7k
    Views
  25. Change of Directors Interest Notice

    formerUser Name of entity PRIMA BIOMED LIMITED (ASXPRR) ABN 90 009 237 889 Name of Director Mr Matthew Lehman Date of last notice 10 Octobe
    0
    Replies
    136
    Views
  26. Change of Directors Interest Notice

    formerUser Name of entity PRIMA BIOMED LIMITED (ASXPRR) ABN 90 009 237 889 Name of Director Ms Lucy Turnbull Date of last notice 05.07.2013
    0
    Replies
    133
    Views
  27. 2013 AGM CEO Address

    formerUser PRR - 2013 AGM CEO Address I would like to say thank you to our shareholders for your continued support of Prima and for your at
    0
    Replies
    141
    Views
  28. Update on CVac Clinical Development Program

    formerUser PRR - Prima BioMed Provides Update on CVac Clinical Development Program Prima BioMed referred to its previous announcements whic
    0
    Replies
    191
    Views
  29. Prima and Neopharm enter into licence for CVac in Israel

    formerUser PRR - Prima and Neopharm enter into licence for CVac in Israel Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) (Pr
    0
    Replies
    167
    Views
  30. Appendix 4C - quarterly

    formerUser PRR - Appendix 4C - quarterly
    0
    Replies
    194
    Views
  31. Picking up

    Pee Jay Lets hope so, a lot of ground to make up. Should be back at that 7-8c mark IMO ...
    1
    Reply
    727
    Views
  32. Has PRR reached the bottom?

    Mr Otto The SP is picking up a bit today with healthy volume too. Wonder what is happening. Maybe it's reached the bottom already. :roll
    4
    Replies
    1.0k
    Views
  33. Change of Directors Interest Notice

    formerUser Name of entity PRIMA BIOMED LIMITED (ASXPRR) ABN 90 009 237 889 Name of Director Mr Matthew Lehman Date of last notice 09 Octobe
    0
    Replies
    247
    Views
  34. Change of Directors Interest Notice

    formerUser Name of entity PRIMA BIOMED LIMITED (ASXPRR) ABN 90 009 237 889 Name of Director Mr Matthew Lehman Date of last notice 03 Octobe
    0
    Replies
    237
    Views
  35. Please explain

    MRGRUMPY Ohhhh ok its not a dud just been shelved for a while cause it is such a great product thats going to help all the cancer patient
    4
    Replies
    908
    Views
  36. Change of Directors Interest Notice

    formerUser Name of entity PRIMA BIOMED LIMITED (ASXPRR) ABN 90 009 237 889 Name of Director Mr Matthew Lehman Date of last notice 18 June 2
    0
    Replies
    216
    Views
  37. Presentation -CAN003 Clinical Trial Analysis

    edcole The CAN-003 protocol is a phase 2 clinical trial of CVac for the treatment of epithelial ovarian cancer patients in remission af
    0
    Replies
    520
    Views
  38. given up

    ant2won had these for a while sold at .043 while I can still get it. all downhill from here on
    0
    Replies
    645
    Views
  39. End points PFS vs OS

    mactrader Hi all, I know that most of you are depressed from Wednesday announcement, but the sky is not falling as Overall survival (OS) s
    0
    Replies
    689
    Views
  40. Its over !!!

    MoneyPenny Criterion Medical results prove more than a trial by: Criterion From: The Australian September 20, 2013 12:00AM OH, joy! Clinica
    3
    Replies
    1.3k
    Views
  41. Rodman & Renshaw Investment Conference

    edcole Interesting presentation on CVa in ovarian cancer at the 15th Annual Rodman & Renshaw Global Investment Conference. CEO Matthe
    0
    Replies
    679
    Views
  42. Bad news?

    SHaGMaSTA Duster, currently a Day trade play thing.
    1
    Reply
    827
    Views
  43. Top-line Analysis of CVac Phase 2 Trial

    formerUser PRR - Top-line Analysis of CVac Phase 2 Trial SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034)
    0
    Replies
    305
    Views
  44. Q4 updates from Conference call

    Pee Jay Used to be one of the most controversial stocks on this site, now hardly discussed. Strange given we are so close to imperative
    2
    Replies
    676
    Views
  45. Appendix 4E & 2013 Full Year Statutory Accounts

    problem with my ego Attachments
    1
    Reply
    389
    Views
  46. Approval received to start CANVAS clinical trials in Korea

    peter121 Approvals all over the world.No any good news at all!!!
    1
    Reply
    452
    Views
  47. PRR - Where to from here

    Pee Jay Huntsman, thanks for the words of encouragement. Its very rare to get any sort of encouragement between members here. Things def
    10
    Replies
    2.1k
    Views
  48. Appendix 4C - quarterly

    formerUser PRR - Appendix 4C - quarterly The quarterly report provides a basis for informing the market how the entitys activities have bee
    0
    Replies
    229
    Views
  49. Response to ASX Price Query

    formerUser PRR - Response to ASX Price Query I refer to your letter dated 11 July 2013 in relation to the ASX Price Query. Prima BioMed Lim
    0
    Replies
    247
    Views
  50. New clinical trial sites activated in Europe for CANVAS

    formerUser PRR - Prima BioMed Activates New Clinical Trial Sites in Europe for CANVAS Prima BioMed announced that it has activated a substa
    0
    Replies
    253
    Views
Page 1 of 10
Your browser is too old for TopStocks and not secure. Please update your browser